QA: Annovis Bio Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001477845_2023_Annovis_Bio_Inc.pdf

Logs

Graph

Absolute values for 0001477845, Annovis Bio Inc.

  xvar xval
0 AssetsCurrent 36,022,069
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 0
4 LiabilitiesCurrent 7,698,539
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 8,995,736
9 ResearchAndDevelopmentExpense 16,515,543
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 182,712
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 36,022,069
1 Liabilities 7,698,539
2 Expenses 25,511,279
3 Revenues 0
4 StockholdersEquity 28,323,530
5 NetIncome -25,328,567
6 ComprehensiveNetIncome -25,328,567
7 BaseVar 34,707,300
8 EconomicCapitalRatio 1.07

Edgar->Model Mapping

Feature Distribution

Change over Time